T he daily use of aspirin in low doses (75-325 mg) is a well-known preventive therapy for cardiovascular disease. 1 Approximately 35% of adults in the United States are estimated to take aspirin regularly for this purpose. 2 Furthermore, the regular use of aspirin seems to reduce the risk of several types of cancer and distant metastasis. 3, 4 However, aspirin can increase the risk of bleeding, especially risk for bleeding of the gastrointestinal tract and hemorrhagic stroke. 5, 6 Nevertheless, the correlation between the daily use of lowdose aspirin and microscopic hematuria in the asymptomatic general population is unknown. We evaluated whether the daily use of aspirin increases the risk of hematuria in a large sample of healthy individuals.
Methods. Data were obtained from asymptomatic healthy adults (Ն20 years old) who underwent general health screening during the period August 2005 through December 2010 at the Health Promotion Center in our institution. After exclusions for missing data, 56 632 participants were included in the analysis. This study was approved by the institutional review board of Seoul National University Bundang Hospital (Seongnam, Republic of Korea).
We prospectively collected data regarding medication use, medical history, and smoking history using a standardized questionnaire. The routine use of drugs including aspirin was checked with a response of either "yes" or "no." Microscopic hematuria was defined as the presence of more than 4 red blood cells per high-power field at urine microscopic analysis. The primary outcome was the relative prevalence of hematuria in aspirin users and nonusers.
We also calculated the relative risk of developing microscopic hematuria among those who did not have hematuria at the initial screening and underwent at least 1 additional health screening during the study period (9199 participants; 17.3%). Finally, we calculated the relative risk of persistent hematuria among those with hematuria at the initial screening who had a second urinalysis within 12 months (1619 participants; 46.0%).
Results. The characteristics of the participants are presented in the Table. There were 4254 participants (7.5%) Of those who did not have hematuria at baseline, 9199 (17.3%) underwent at least 1 follow-up screening at a median (range) of 13 (4-64) months after initial screening. At the second screening, the incidence of microscopic hematuria in these participants was 4.4% (27 of 614) in aspirin users and 4.1% (348 of 8585) in nonusers (P = .67).
Among 1619 participants with microscopic hematuria at baseline who underwent a second urinalysis within 12 months, 911 (56.3%) showed persistent microscopic hematuria; these rates were not different between aspirin users (60.6% [57 of 94]) and nonusers (56.0% [854 of 1525]; P = .39).
Discussion. In a large study of asymptomatic persons, we found no association of low-dose aspirin use with microscopic hematuria in either cross-sectional or longitudinal analyses. Previously, 1 study suggested that lowdose aspirin use does not increase risk of hematuria; however, it was a small study including only 69 patients. 7 Our results suggest that clinicians should use the same approach to evaluation of the causes of microscopic hematuria in persons using low-dose aspirin as in those who are not taking aspirin. 1 It can be self-imposed in the case of extreme dieting, religious fasts, and chaotic work schedules. 2, 3 It can be medically imposed in the case of fasting before blood draws or surgery. 4 In extreme cases, it can be caused by external circumstances, such as food shortages, natural disasters, or poverty. 5 Food deprivation has been shown to alter the quantity of food people buy or consume. 6, 7 However, little attention has been given to how fasting affects the composition of people's food choices. Do people just buy more when food deprived, or do they specifically increase purchases of high-calorie, relative to low-calorie, foods?
There is some reason to suspect that shifts in purchase following food deprivation would indeed focus on increases in high-calorie foods. Fasting has been shown to increase brain reactivity to particular types of food over others. 8 Fasting participants showed increased activation in brain areas associated with reward, including the ventral striatum, amygdala, anterior insula, and medial 
